One of the objectives of Benzinga is to offer the best coverage by interviewing the world's top executives. In this endeavor, we have interviewed more than 20 publicly-traded companies in 2016.
Is there anybody you want to hear from? Let us know by emailing feedback@benzinga.com and we'll try to get them on the dial before 2016 is over!
- Cytosorbents CTSO CEO Philip Chan talked about the way its blood purification technology is a game changer in healthcare.
- RetailMeNot SALE CFO Scott Di Valerio discussed about Brexit impact and desktop usage.
- Agree Realty ADC CEO Joey Agree discussed REITs and geographical agnosticism. He also talked about the real estate market.
- Mitek Systems MITK CFO Russell Clark refuted reports and said its business continued to perform well. He clarified that retired chairman, John Thornton, was liquidating his position for estate planning.
- Sodastream SODA CEO Daniel Bimbaum discussed Keurig, Beer Bar and strength in Europe.
- NuVasive NUVA CEO Greg Lucier talked about the company's biggest weakness, Brazil and M&A in a wide-ranging interview.
- Aldeyra Therapeutics ALDX CEO Todd Brady discussed drug potential, cash and fresh talent.
- Sequential Brands Group SQBG CEO Yehuda Shmidman discussed about the recent acquisition and its "Playbook"
- Centrus Energy LEU CEO Morris Bawabeh talked about the future of the uranium supplier.
- Planet Fitness PLNT CEO Chris Rondeau disagreed with the "misleading" statements of Spruce Point Capital.
- Digital Ally DGLY CEO Stan Ross talked about the TASER lawsuit.
- Intralinks IL CEO Ron Hovsepian discussed boosting outlook and promising client pipeline.
- Re/Max RMAX CEO Dave Liniger and CFO Karri Callahan, explained the reasons for reducing outlook.
- LendingTree TREE CEO Doug Lebda said the stock looked "incredibly" attractive.
- Nautilus NLS CEO Bruce Cazenave and CFO Sid Nayar explained reasons for expecting continued growth.
- Second Sight Medical Products EYES Chairman and co-founder Robert Greenberg discussed the company's future.
Here are some other execs we've chatted with:
- Former JPMorgan fintech guru Pete Casella joined Point72 to discover innovative investments
- WiseBanyan's CEOs believe investing should be a right and not a privilege enjoyed by those having money and links to the markets.
- MaxMyInterest CEO discussed its three-year anniversary and the future of fintech.
- Wealth-X's President on expanding ultra high-net-wealthy population and spending habits.
ALDXAldeyra Therapeutics Inc
$4.71-3.48%
CTSOCytoSorbents Corp
$0.92000.55%
DGLYDigital Ally Inc
$0.50004.17%
INOInovio Pharmaceuticals Inc
$1.82-1.09%
LEUCentrus Energy Corp
$66.68-0.18%
MITKMitek Systems Inc
$11.20-2.06%
PLNTPlanet Fitness Inc
$99.420.16%
RMAXRE/MAX Holdings Inc
$10.86-1.72%
TREELendingTree Inc
$39.61-%
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in